Company: ATRA
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001193125-25-276209
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits.

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release, dated November 12, 2025                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        ATARA BIOTHERAPEUTICS, INC.                                                                        
  Date: November 12, 2025      By:      /s/ Yanina Grant-Huerta                                                                            
                                        Yanina Grant-Huerta